Synapse - Zhigang Zhang

Results (427)

Stereotactic body radiotherapy for sarcoma pulmonary metastases

Meeting Abstract

Lebow, E. S.; Lobaugh, S.; Zhang, Z.; Dickson, M.; Thornton, K.; Rosenbaum, E.; D'Angelo, S.; Nacev, B.; Shepherd, A. F.; Shaverdian, N.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Phase II randomized trial comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis

Meeting Abstract

Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Betof Warner, A.; Yu, H.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Biomarkers associated with pulmonary exacerbations in a prospective, placebo-controlled, randomized trial of nintedanib for the treatment of radiation pneumonitis

Meeting Abstract

Moore, Z. R.; Huang, X.; Lobaugh, S.; Geyer, A.; Gelblum, D.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J.; Zauderer, M.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

40 Gray in 5 fractions for salvage re-irradiation of spine lesions previously treated with stereotactic body radiotherapy

Meeting Abstract

Moore, A.; Zhang, Z.; Schmitt, A.; Higginson, D. S.; Mueller, B. A.; Zinovoy, M.; Gelblum, D.; Yerramilli, D.; Xu, A. J.; Brennan, V. S.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose rate (HDR) vs. low-dose rate (LDR) brachytherapy boost

Meeting Abstract

Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V. S.; Beaudry, J.; Cohen, G.; Damato, A. L.; Zhang, Z.; Zelefsky, M. J.
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Focal dose intensification to the dominant intraprostatic lesion (DIL) using an MR-linac adaptive-planning approach for prostate cancer: Dosimetric outcomes and early toxicity

Meeting Abstract

Brennan, V. S.; Burleson, S.; Kostrzewa, C.; Scripes, P. G.; Subashi, E.; Zhang, Z.; Tyagi, N.; Zelefsky, M. J.
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

CNS outcomes in ALK fusion positive NSCLC patients with BM who received alectinib with or without local therapy

Meeting Abstract

Miao, E.; Lebow, E. S.; Eichholz, J.; Flynn, J.; Zhang, Z.; Hubbeling, H. G.; Beal, K.; Moss, N. S.; Yu, K.; Yang, J. T.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Breast cancer presenting with intravascular tumor emboli in axillary soft tissue: Recurrence risk and radiotherapy outcomes

Meeting Abstract

Sarkar, R. R.; Lavery, J.; Zhang, Z.; Gillespie, E. F.; Mueller, B. A.; Zinovoy, M.; Cuaron, J. J.; McCormick, B.; Khan, A. J.; Cahlon, O.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Regional nodal irradiation for breast cancer using volumetric modulated arc therapy: Echocardiographic functional outcomes

Meeting Abstract

Yu, A.; White, C.; Zhang, Z.; Gillespie, E. F.; McCormick, B.; Khan, A. J.; Powell, S. N.; Cahlon, O.; Braunstein, L. Z.
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost

Journal Article

Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V.; Beaudry, J.; Cohen, G.; Damato, A.; Zhang, Z.; Zelefsky, M. J.
Brachytherapy (2022)

Fulltext@MSK | Save